The MAS Omni•CARDIO control from Thermo Fisher Scientific, Fremont, Calif, consolidates routine cardiac markers, including Troponin I and T, CK-MB, Myoglobin, NT-proBNP, and BNP-32, with several new cardiac/STAT markers including Myeloperoxidase, hCG, D-Dimer, and Procalcitonin.
These new analytes extend the usage of MAS Omni•CARDIO controls into the ER/ICU hospital setting, where rapid turnaround and reporting of tests is critical to the support of potentially life threatening situations.
MAS Omni•CARDIO offers five control levels—the available Ultra Low and Low options offer specific Troponin I and T low-level challenges, which are increasingly demanded by clinical laboratories.
